68 results
6-K
EX-1.1
IPHA
Innate Pharma
6 Feb 24
Current report (foreign)
5:05pm
Code, or any applicable anti-corruption laws, rules, or regulations of the European Union or any other jurisdiction in which the Company and its … , the United Nations Security Council, the European Union, His Majesty’s Treasury, any French government agency or other relevant sanctions authority
424B5
mrtxsn5j ya
6 Feb 24
Prospectus supplement for primary offering
5:00pm
6-K
EX-99.1
ennsfsuu9s0
4 Jan 24
FDA lifts partial clinical hold on lacutamab clinical programFatal case related to disease progression and unrelated to the treatment
6:01am
F-3
8lto2s3 ndtk6kr
20 Dec 23
Shelf registration (foreign)
4:45pm
F-3
EX-3.1
h8r c3ptnqg86j41l
20 Dec 23
Shelf registration (foreign)
4:45pm
6-K
EX-99.1
ai3o7vmz vnq1
11 Dec 23
Innate Pharma S.a. 6-K
6:01am
6-K
EX-99.1
4k2woiohps8i mr8
27 Nov 23
Innate Pharma S.a. 6-K
6:00am
6-K
EX-99.1
aligya6 795rlt9
5 Oct 23
Innate Pharma S.a. 6-K
6:00am
6-K
EX-99.1
6ttwh trvregqzoei
22 Sep 23
Innate Pharma S.a. 6-K
6:00am
6-K
EX-99.2
xhge4y6zisxltk riq
14 Sep 23
Innate Pharma Reports First Half 2023 Financial Results and Business Update
6:27am
6-K
EX-99.1
ndq4sc13w 91aqo69j6u
14 Sep 23
Innate Pharma Reports First Half 2023 Financial Results and Business Update
6:27am
6-K
EX-99.1
s6qc6
14 Sep 23
Innate Pharma S.a. 6-K
6:00am
6-K
EX-99.1
ltvok
16 Jun 23
Innate Pharma S.a. 6-K
6:00am
6-K
EX-99.1
eqqzthn f0sxtk6
12 Jun 23
Innate Pharma S.a. 6-K
6:01am
6-K
EX-1.1
p44 849dv6aath
26 Apr 23
Current report (foreign)
4:02pm
424B5
l7qcci4a6d u77id8
26 Apr 23
Prospectus supplement for primary offering
4:01pm